HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eliete Bouskela Selected Research

Nitroprusside (Sodium Nitroprusside)

1/2018Effects of Selenium in the Microcirculation of Fructose-Fed Hamsters.
1/2017Structural and functional changes in the microcirculation of lepromatous leprosy patients - Observation using orthogonal polarization spectral imaging and laser Doppler flowmetry iontophoresis.
1/2015α-Tocopherol Improves Microcirculatory Dysfunction on Fructose Fed Hamsters.
1/2014Chronic aerobic exercise associated to dietary modification improve endothelial function and eNOS expression in high fat fed hamsters.
11/2011High fat diet induces central obesity, insulin resistance and microvascular dysfunction in hamsters.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eliete Bouskela Research Topics

Disease

18Ischemia
01/2022 - 03/2002
14Insulin Resistance
01/2021 - 05/2006
11Inflammation (Inflammations)
01/2022 - 10/2006
9Hyperemia
01/2022 - 10/2008
9Obesity
01/2022 - 12/2007
9Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2015 - 04/2006
7Hypertension (High Blood Pressure)
07/2018 - 12/2007
6Type 2 Diabetes Mellitus (MODY)
01/2022 - 05/2006
5Sepsis (Septicemia)
01/2017 - 09/2011
4Hyperglycemia
01/2018 - 06/2007
4Overweight
07/2017 - 11/2012
4Endotoxemia
03/2015 - 01/2011
3Weight Loss (Weight Reduction)
01/2022 - 07/2008
3Reperfusion Injury
01/2020 - 02/2003
3Fibrosis (Cirrhosis)
01/2019 - 01/2016
3Body Weight (Weight, Body)
11/2018 - 05/2007
3Arterial Occlusive Diseases (Arterial Occlusive Disease)
04/2015 - 05/2011
2Neoplasms (Cancer)
07/2022 - 09/2011
2Hypertrophy
06/2021 - 01/2021
2Hemorrhagic Shock
11/2019 - 11/2012
2Atherosclerosis
01/2018 - 11/2013
2Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 05/2007
2Septic Shock (Toxic Shock Syndrome)
08/2014 - 10/2013
2Weight Gain
01/2014 - 06/2007
2Shock
11/2012 - 12/2010
2Diabetes Mellitus
01/2011 - 12/2007
2Hyperinsulinism (Hyperinsulinemia)
12/2010 - 06/2007
2Edema (Dropsy)
06/2007 - 11/2006
1Venous Insufficiency
10/2021
1Crohn Disease (Crohn's Disease)
03/2020
1Ulcerative Colitis
03/2020
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
03/2020
1Atherosclerotic Plaque (Atheroma)
01/2020
1Herpes Zoster
01/2020
1Cardiomegaly (Heart Hypertrophy)
01/2020

Drug/Important Bio-Agent (IBA)

14Glucose (Dextrose)FDA LinkGeneric
01/2021 - 05/2006
10Biomarkers (Surrogate Marker)IBA
06/2021 - 08/2014
7Histamine (Histamine Dihydrochloride)FDA Link
01/2020 - 03/2002
6Triglycerides (Triacylglycerol)IBA
01/2018 - 03/2007
5Insulin (Novolin)FDA Link
01/2021 - 05/2006
5C-Reactive ProteinIBA
01/2021 - 10/2008
5LipidsIBA
10/2020 - 10/2008
5Metformin (Glucophage)FDA LinkGeneric
10/2020 - 05/2006
5CholesterolIBA
01/2018 - 10/2008
5Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric
01/2018 - 11/2011
5Acetylcholine (Acetylcholine Chloride)FDA Link
01/2018 - 11/2011
5Fibrinogen (Factor I)FDA Link
12/2015 - 05/2006
4LipopolysaccharidesIBA
01/2021 - 12/2010
4Vasodilator Agents (Vasodilators)IBA
01/2018 - 05/2007
4FructoseIBA
01/2018 - 06/2007
4Estradiol (Delestrogen)FDA LinkGeneric
10/2016 - 12/2007
3Nitroglycerin (Dynamite)FDA LinkGeneric
01/2022 - 04/2015
3FlavonoidsIBA
10/2021 - 03/2004
3Peptides (Polypeptides)IBA
01/2021 - 01/2019
3Norepinephrine (Noradrenaline)FDA LinkGeneric
11/2019 - 11/2012
3Endothelin-1 (Endothelin 1)IBA
01/2019 - 11/2013
3AntioxidantsIBA
01/2018 - 02/2003
3Rosiglitazone (Avandia)FDA Link
11/2007 - 05/2006
3AdiponectinIBA
11/2007 - 10/2006
2Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2019
2Arginine (L-Arginine)FDA Link
01/2022 - 08/2014
2Glucagon-Like Peptide 1 (GLP 1)IBA
01/2021 - 01/2020
2VildagliptinIBA
10/2020 - 01/2019
2Pharmaceutical PreparationsIBA
03/2020 - 01/2019
2Olive OilIBA
01/2020 - 05/2007
2Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
01/2019 - 11/2018
2Nonesterified Fatty Acids (NEFA)IBA
01/2019 - 03/2007
2Endothelins (Endothelin)IBA
07/2018 - 01/2018
2oxidized low density lipoproteinIBA
01/2018 - 04/2015
2HDL CholesterolIBA
01/2018 - 10/2008
2LeptinIBA
07/2017 - 01/2014
2Uric Acid (Urate)IBA
07/2017 - 01/2011
2Propranolol (Inderal)FDA LinkGeneric
01/2017 - 01/2016
2Fish OilsIBA
01/2015 - 05/2007
2Fluorescein (Funduscein)FDA LinkGeneric
12/2013 - 08/2012
2Dextrans (Dextran)FDA Link
12/2013 - 08/2012
2AdipokinesIBA
11/2013 - 10/2006
2fluorescein isothiocyanate dextranIBA
08/2012 - 03/2002
2BradykininIBA
08/2012 - 11/2006
2Drinking WaterIBA
12/2010 - 06/2007
2SolutionsIBA
12/2010 - 06/2007
2nitronesIBA
06/2009 - 05/2007
1GraphiteIBA
07/2022
1lipopolysaccharide-binding proteinIBA
01/2021
1Hormones (Hormone)IBA
01/2021
1Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA
01/2021
1GhrelinIBA
01/2021
1Glucagon (Glukagon)FDA Link
01/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2020
1AntibodiesIBA
03/2020
1Infliximab (Remicade)FDA Link
03/2020
1Adalimumab (Humira)FDA Link
03/2020
1Fatty Acids (Saturated Fatty Acids)IBA
01/2020

Therapy/Procedure

8Therapeutics
03/2020 - 04/2006
3Resistance Training
01/2021 - 01/2014
3Fluid Therapy (Oral Rehydration Therapy)
11/2019 - 11/2012
2Bariatric Surgery
01/2022 - 01/2021
2Gastric Bypass (Roux-en-Y Gastric Bypass)
01/2022 - 01/2021
1Quantum Dots (Quantum Dot)
07/2022
1Drug Therapy (Chemotherapy)
07/2022